Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

Add To Watchlist

NDAQ:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG gets positive preclinical results for ALPHA-0602 drug

View:

Post by StockHawk1 on Apr 20, 2022 5:26pm

$ACOG gets positive preclinical results for ALPHA-0602 drug

For those interested in the biopharma space, Alpha Cognition Inc. ($ACOG.v $ACOGF) is a company working on creating medication to help those with neurodegenerative disorders.

It recently announced that it received positive preclinical data from its ALPHA-0602 gene therapy program.

$ACOG's ALPHA-0602 is designed to increase brain progranulin levels and reduce the effects of oxidative stress which is associated with ALS.

Pre-clinical results demonstrated that ALPHA-0602 further increased progranulin levels and decreased motor neuron cell death in in vitro models along with other positive results.

Full results here: https://finance.yahoo.com/news/alpha-cognition-announces-positive-data-130000103.html

IMO these results are a big step forward for $ACOG and its ALPHA-0602 drug. Considering the lack of available medicines for ALS $ACOG could really blow up as it moves its drugs towards approval phases.

$ACOG @ $1.03

MC $63.341M

427